Double-blind controlled crossover high-dose study of Azaribine in psoriasis*
- 1 February 1975
- journal article
- clinical trial
- Published by Wiley in British Journal of Dermatology
- Vol. 92 (2) , 199-205
- https://doi.org/10.1111/j.1365-2133.1975.tb03059.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Urine Orotic Acid-Orotidine Levels in Azaribine-Treated Patients with PsoriasisJournal of Investigative Dermatology, 1973
- Azaribine in the treatment of psoriasis. A low dose, double-blind evaluationArchives of Dermatology, 1973
- Psoriasis with hydroxyurea. An 18-month study of 60 patientsArchives of Dermatology, 1973
- Malignancy during methotrexate and steroid therapy for psoriasisArchives of Dermatology, 1971
- Topically applied mechlorethamine in the treatment of psoriasisArchives of Dermatology, 1971
- Azaribine for mycosis fungoidesArchives of Dermatology, 1971
- Methotrexate for psoriasis. A new therapeutic scheduleArchives of Dermatology, 1971
- A Double-Blind Study of Azaribine in the Treatment of PsoriasisAnnals of Internal Medicine, 1970
- Beneficial Effects of Triacetyl Azauridine in Psoriasis and Mycosis FungoidesAnnals of Internal Medicine, 1966
- The Effect of Triacetyl Azauridine on Psoriasis*Journal of Investigative Dermatology, 1964